Effect of Intensive Glycemic Control and Diabetes Complications on Lower Urinary Tract Symptoms in Men With Type 1 Diabetes
Open Access
- 26 January 2009
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 32 (4) , 664-670
- https://doi.org/10.2337/dc07-2375
Abstract
OBJECTIVE: Although diabetes is known to result in lower urinary tract symptoms (LUTS) in men, it remains unclear if glycemic control can mitigate urinary symptoms. We studied how diabetic characteristics are related to LUTS in the men who completed the urological assessment component (UroEDIC) of the Epidemiology of Diabetes Interventions and Complications (EDIC) follow-up study of the Diabetes Control and Complications Trial (DCCT) participants. RESEARCH DESIGN AND METHODS: Study participants were men who completed the UroEDIC questionnaire at the year 10 DCCT/EDIC follow-up examination, which included data on genitourinary tract function and the American Urological Association Symptom Index (AUASI). Analyses were conducted to assess how treatment arm and diabetes characteristics were associated with LUTS using logistic regression. RESULTS: Of the 591 men who completed the AUASI questions, nearly 20% (n = 115) had AUASI scores in the moderate to severe category for LUTS (AUASI score ≥8). No associations were observed between LUTS and treatment arm, or A1C levels at the DCCT baseline or end-of-study or at the year 10 EDIC (UroEDIC) examination. Of the diabetes complications studied, only erectile dysfunction at the UroEDIC examination was associated with LUTS. CONCLUSIONS: These data from the UroEDIC cohort do not support the assumption that intensive glycemic control results in decreased lower urinary tract symptom severity in men with type 1 diabetes. This result may be due to a true lack of effect, or it may be due to other factors, for example, the relatively young age of the cohort.Keywords
This publication has 22 references indexed in Scilit:
- The Effect of Intensive Glycemic Treatment on Coronary Artery Calcification in Type 1 Diabetic Participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) StudyDiabetes, 2006
- Tracking of Longitudinal Changes in Measures of Benign Prostatic Hyperplasia in a Population Based CohortJournal of Urology, 2006
- Diabetes and benign prostatic hyperplasia progression in Olmsted County, MinnesotaUrology, 2006
- Insights from The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study on The Use of Intensive Glycemic Treatment to Reduce The Risk of Complications of Type 1 DiabetesEndocrine Practice, 2006
- Hemoglobin A1c Measurements over Nearly Two Decades: Sustaining Comparable Values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications StudyClinical Chemistry, 2005
- The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik studyBJU International, 2003
- Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes MellitusNew England Journal of Medicine, 2003
- The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications TrialDiabetes, 1995
- Metabolic MemoryNew England Journal of Medicine, 1980
- Diabetes Mellitus in Patients with Benign Prostatic HyperplasiaBMJ, 1968